Dr. Arthur J. Frazier, MD

Dr. Frazier practices at Oncologic Specialists in Saint Louis, Missouri.

Dr. Frazier's NPI, 1609899640, was assigned on July 25, 2006. Dr. Frazier graduated from VCU School of Medicine in 1990. Dr. Frazier holds Michigan license 055857.

Dr. Frazier's primary practice is Oncologic Specialists, at 11475 Olde Cabin Rd, Saint Louis, MO 63141 in Saint Louis County. The practice phone is (586) 493-7510.

Dr. Frazier's primary practice is Oncologic Specialists in Saint Louis, Missouri. Dr. Frazier is also affiliated with Trinity Health Oakland Hospital. The medical group on file is Karmanos Cancer Institute at McLaren Macomb (Karmanos Cancer Center). Dmand AI also links Dr. Frazier to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frazier practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Frazier's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Frazier is board certified in radiation oncology by the American Board of Radiology. Dr. Frazier is licensed in Michigan.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Frazier treats.

CMS data shows 2,362 Medicare services from Dr. Frazier across 20 procedure codes in 2024, for 455 Medicare patients. Medicare paid $157,326 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 455 Medicare patients who saw Dr. Frazier in 2024. The largest group is 75 to 84, with 204 patients. 75% of them have cancer, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Frazier's median patient age at 75, with 37% women.

In 2024, Dr. Frazier wrote 4,698 Medicare Part D claims for 628 patients. 94% of them were for generic drugs. CMS names the drug for 4,139 of them, across 93 drugs with 11 or more claims each, at $428,083 in total drug cost. In 2023, CMS named 4,181 claims across 98 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Frazier for performance year 2024, reported as part of a group. Dr. Frazier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Frazier as offering telehealth.

Dmand AI links 2 papers to Dr. Frazier, published from 2011 to 2023. The most frequent topics are Prostatic Neoplasms. Dr. Frazier's most frequent co-authors are Kevin Dale Courtney, MD, Samantha F. Culver, DO and Salman A. Fateh, DO.

Dmand AI links Dr. Frazier to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 8 general payments to Dr. Frazier from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Telix Pharmaceuticals paid the most, $249.

Dr. Frazier graduated from VCU School of Medicine in 1990.

Dr. Frazier is in network with 8 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.